Search results for "Solid tumours"

showing 4 items of 4 documents

Individual and neighbourhood socioeconomic measures and the risk of non-central nervous system solid tumours in children: A nationwide register-based…

2021

Abstract Background The aetiology for most solid tumours in childhood is largely unknown. The lack of evidence concerns also the relationship between socioeconomic position (SEP) and risk of childhood solid tumours other than in the central nervous system (CNS). We sought to access the association between individual and neighbourhood SEP measures and risk of childhood non-CNS solid tumours in Denmark and to evaluate whether associations varied by measure of SEP, time point of SEP assessment (during pregnancy versus before diagnosis) and tumour type. Methods We conducted a nationwide case-control study based on Danish registry data. We identified all children born in 1980–2013 and diagnosed …

AdultCancer ResearchRegister-based studyAdolescentEpidemiologyDenmarkPopulationCentral Nervous System NeoplasmsArea-based socioeconomic positionDanishYoung Adult03 medical and health sciences0302 clinical medicinePregnancyResidence CharacteristicsRisk FactorsmedicineHumansRegistries030212 general & internal medicineChildeducationSocioeconomic statusNeighbourhood (mathematics)Pregnancyeducation.field_of_studybusiness.industryChildhood solid tumoursInfant NewbornCase-control studyInfantmedicine.diseaselanguage.human_languageCancer registrySocioeconomic positionSocioeconomic FactorsOncologyCase-Control StudiesChild Preschool030220 oncology & carcinogenesislanguageEtiologyFemalebusinessDemographyCancer Epidemiology
researchProduct

A phase I dose-escalation study of the immunocytokine EMD 521873 (Selectikine) in patients with advanced solid tumours.

2012

Abstract Background EMD 521873 (Selectikine), an immunocytokine comprising a DNA-targeting antibody, aimed at tumour necrosis, fused with a genetically modified interleukin-2 (IL-2) moiety, was investigated in this first-in-human phase I study. Methods Patients had metastatic or locally advanced solid tumours failing previous standard therapy. Selectikine was administered as a 1-hour intravenous infusion on 3 consecutive days, every 3weeks. A subgroup of patients also received 300mg/m 2 cyclophosphamide on day 1 of each cycle. Escalating doses of Selectikine were investigated with the primary objective of determining the maximum tolerated dose (MTD). Results Thirty-nine patients were treate…

AdultMaleCancer Researchmedicine.medical_specialtyNecrosisCyclophosphamideMaximum Tolerated DoseLymphocyteRecombinant Fusion ProteinsSelectikineAntineoplastic AgentsPharmacologyGastroenterologyEMD 521873Young AdultPhase IDose-escalationInternal medicineNeoplasmsmedicineHumansAgedbiologyDose-Response Relationship Drugbusiness.industryEosinophilMiddle AgedRashAdvanced solid tumoursmedicine.anatomical_structureOncologyToxicitybiology.proteinInterleukin-2SelectikineFemalemedicine.symptomAntibodybusinessmedicine.drugEuropean journal of cancer (Oxford, England : 1990)
researchProduct

Membrane-bound exosomal HSP70 as a biomarker for detection and monitoring of malignant solid tumours: a pilot study

2019

Abstract Background Cancer is the second leading cause of death globally. Early detection and disease management lead to a better survival rate. Consequently, discovery of novel methods in cancer early diagnosis is a field of active research. Minimally invasive liquid biopsies are generating growing interest. Circulating tumour cells (CTCs) have been identified in patients’ blood; nevertheless, these cells are rare and heterogeneous. Exosomes are extracellular nanovesicles released into the extracellular environment via the endosomal vesicle pathway and found in different body fluids. Exosomes deliver bioactive cargo such as proteins, mRNA and miRNA to recipient cells in the tumour environm…

EndosomeMedicine (miscellaneous)HSP70-exosomesStudy Protocol03 medical and health sciences0302 clinical medicinemicroRNAmedicineLiquid biopsySurvival rate030304 developmental biologyPilot studySolid tumours0303 health scienceslcsh:R5-920Liquid biopsyCancer diagnosis and monitoringbusiness.industryCancermedicine.diseaseMicrovesicles3. Good healthBiomarker (cell)030220 oncology & carcinogenesisCancer cellCancer researchbusinesslcsh:Medicine (General)Pilot and Feasibility Studies
researchProduct

SOFT TISSUE SARCOMAS: Surgical Results from Italian Spft Tissue Sarcoma Group

1993

The Authors report the experience of the Italian Society of Paediatric Haematology and Oncology (AIEOP) in the treatment of Rhabdomyosarcoma, according to the Protocol ICS-RMS 88, is here reported.

Settore MED/38 - Pediatria Generale E SpecialisticaPaediatric solid tumours sarcoma Italian protocolSettore MED/20 - Chirurgia Pediatrica E Infantile
researchProduct